Advertisement
The Centers for Medicare & Medicaid Services has released the Clinical Laboratory Fee Schedule

Payment for Laboratory Tests Set to Reduce Starting Jan. 1, 2018

0
CMS Clinical Laboratory Fee Schedule to result in drop in payments for physician office-based tests
High intake of fermented milk products

Yogurt, But Not Milk, May Lower Hip Fracture Risk

0
Findings based on combination of high intake of fermented milk products and fruits, vegetables
A targeted microbiome intervention

Microbiome Intervention With Niacin Aids Insulin Sensitivity

0
Delayed-release microcapsules of nicotinic acid induce favorable microbiome changes
Almost 30 percent of eligible practices failed to register and report data in the first year of the Physician Value-Based Payment Modifier program

Year One Results Out for Value-Based Payment Modifier Program

0
Overall, 29.3 percent of eligible practices failed to register and report data and received a penalty
The TIMI (Thrombolysis in Myocardial Infarction) Risk Score for Secondary Prevention is an accurate predictor of atherothrombotic disease among patients with type 2 diabetes

Expanded TIMI Risk Score Deemed Practical in Diabetes

0
Atherothrombotic disease risk assessment based upon 10 readily available clinical variables
Among individuals with end-stage renal disease

Recent Decrease in Excess Risk of All-Cause Mortality in ESRD

0
Decrease in excess risk of all-cause mortality from 1995 to 2013 for those with end-stage renal disease
A program that integrates clinical pharmacists into established primary care medical home practices helps patients achieve better disease management for high blood pressure and diabetes mellitus

Pharmacist Participation in Medical Homes Aids Outcomes

0
Findings based on disease management goals for diabetes, blood pressure control
Telemedicine follow-up enables more comprehensive diabetes foot ulcer care

Telemedicine Facilitates Diabetes Foot Ulcer Care

0
However, home-based telemedicine posed some technical and logistic challenges
Stricter glycemic control during short-term intensive insulin therapy for newly diagnosed type 2 diabetes patients is associated with a higher likelihood of remission at one year

Stricter Short-Term Glycemic Control May Increase Remission

0
Findings among newly diagnosed diabetes patients undergoing short-term intensive insulin therapy
Patients with diabetes report worse quality of life with more intensified treatment

Measuring Quality of Life Important With Diabetes Tx

0
Predictors of patient-reported outcomes vary by outcome examined